–ë–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã: –ü—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞, –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, –ª–µ—á–µ–Ω–∏–µ : Impact Factor & More
eISSN: 2619-1156pISSN: 2221-996X
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
–ë–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã: –ü—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞, –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, –ª–µ—á–µ–Ω–∏–µ Journal Specifications
| Overview | |
| Publisher | Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» |
| Language | Russian |
| Publication Time | 8 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Russian |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in –ë–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã: –ü—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞, –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, –ª–µ—á–µ–Ω–∏–µ ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in –ë–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã: –ü—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞, –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, –ª–µ—á–µ–Ω–∏–µ
Production and functional activity of scFv fragments obtained from recombinant antibodies against influenza virus
- 26 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Protective efficacy of combined monoclonal antibody docaravimab and miromavimab preparation against classical rabies virus: A preclinical study in BALB/c mice
- 19 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Pharmacokinetic assessment of two IgG1 kappa monoclonal antibodies neutralising the SARS-CoV-2: A study in Syrian hamsters and ICR CD1 outbred mice
- 19 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Clinical trials and post-marketing studies of anti-rabies monoclonal antibodies for post-exposure prevention: A review
- 19 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Human hepatitis B immunoglobulin for intravenous administration: Development, quality control, viral safety, and pharmacokinetics research
- 19 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Antiviral inhalation medicinal product based on interferon alpha-2b: A study of efficacy, subchronic toxicity, and toxicokinetics in rodents
- 19 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Production and functional activity of scFv fragments obtained from recombinant antibodies against influenza virus
- 26 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Protective efficacy of combined monoclonal antibody docaravimab and miromavimab preparation against classical rabies virus: A preclinical study in BALB/c mice
- 19 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Pharmacokinetic assessment of two IgG1 kappa monoclonal antibodies neutralising the SARS-CoV-2: A study in Syrian hamsters and ICR CD1 outbred mice
- 19 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Clinical trials and post-marketing studies of anti-rabies monoclonal antibodies for post-exposure prevention: A review
- 19 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Human hepatitis B immunoglobulin for intravenous administration: Development, quality control, viral safety, and pharmacokinetics research
- 19 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
Antiviral inhalation medicinal product based on interferon alpha-2b: A study of efficacy, subchronic toxicity, and toxicokinetics in rodents
- 19 Dec 2025
- Biological Products. Prevention, Diagnosis, Treatment
FAQs on –ë–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã: –ü—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞, –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, –ª–µ—á–µ–Ω–∏–µ
How many articles did –ë–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã: –ü—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞, –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, –ª–µ—á–µ–Ω–∏–µ publish last year? 
What is the eISSN & pISSN for –ë–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã: –ü—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞, –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, –ª–µ—á–µ–Ω–∏–µ?
Who is the publisher of –ë–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã: –ü—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞, –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, –ª–µ—á–µ–Ω–∏–µ?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations